Skip to main
BCPC
BCPC logo

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is projected to experience growth in earnings per diluted share, with estimates increasing to $4.73 for 2025 and $5.17 for 2026, reflecting positive momentum driven by the strength of its Human Nutrition and Health segment. The company's recent financial performance showcased a top-line revenue of $255.5 million for 2Q25, which exceeded expectations and demonstrated a modest increase from both the prior quarter and the previous year. Additionally, with expectations of improving gross and net margins and a potential path to being debt-free by the end of next year, Balchem's robust balance sheet positions the company favorably for future growth and possible accretive M&A opportunities.

Bears say

Balchem Corporation's stock outlook is negatively impacted by several financial challenges, primarily reflected in its declining P/E multiple, which has decreased to 37.9x from 39.6x amid overall weakening of the share prices and earnings multiples in the comparables universe. Moreover, the company has reported sales in its animal health and nutrition segment of $56.4 million, which fell short of the estimated $60 million, alongside its industrial products segment realizing only $1.4 million in revenue against a projected $1.6 million. Contributing to this negative sentiment are risks related to slower-than-anticipated growth in core businesses, inflationary pressures, and the potential failure of its partner to secure FDA approval for a critical autism drug, as well as disruptions to operations in Europe due to regional conflicts.

Balchem (BCPC) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 2 analysts, Balchem (BCPC) has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $176, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $176, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.